Stonepine Capital Management, LLC

Position in BIOA — BioAge Labs, Inc.

CIK 1440771 BEND, OR

Back to BIOA Full portfolio

Position in BIOA

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$490,200

-$384,300 QoQ

Shares Held

20,000

-60.0% QoQ

Ownership

0.044%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

#93

of 151 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in BIOA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Stonepine Capital Management, LLC holds $17,591,704 across 4 Drug Manufacturers - Specialty & Generic names. BIOA ranks #4 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EOLS	Evolus, Inc.	1,590,162	$11,035,724
2	INDV	Indivior Pharmaceuticals, Inc.	100,000	$4,103,000
3	AYTU	Aytu Biopharma, Inc	912,921	$1,962,780
4	BIOA	BioAge Labs, Inc. This page	20,000	$490,200

All Filings in BIOA

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$490,200	20,000	-60.0%	Shares	Sole	2026-08-17
2026-03-31	$874,500	50,000	+11.1%	Shares	Sole	2026-05-14
2025-12-31	$595,350	45,000	-76.1%	Shares	Sole	2026-02-13
2025-09-30	$1,108,797	188,571	+24.8%	Shares	Sole	2025-11-13
2025-06-30	$623,981	151,085	+202.2%	Shares	Sole	2025-08-13
2025-03-31	$188,000	50,000	—	Shares	Sole	2025-05-14
No filing history on record for this holder in this stock.